A Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction with Buprenorphine in Adults with Opioid Use Disorder Prior to First Dose of VIVITROL.

Administered By

Psychiatry & Behavioral Sciences, Addiction

Awarded By

Alkermes, plc

Contributors

Mannelli, Paolo Principal Investigator
Swartz, Marvin Stanley Co-Principal Investigator

Start/End

January 1, 2016 - December 31, 2019